Carlisle Buys Plasti-Fab & Enhances its Position in Polystyrene Market

Published on 19 Dec 2024 on Zacks · via Yahoo Finance

Carlisle Companies Incorporated CSL recently completed the acquisition of the expanded polystyrene...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights CSL's estimated fair value is AU$408 based on 2 Stage Free Cash Flow to Equity CSL i...

Simply Wall St. · via Yahoo Finance 10 Jan 2025

Carlisle Companies Incorporated CSL recently announced that it has signed a definitive deal to...

Zacks · via Yahoo Finance 24 Dec 2024

Carlisle Companies Incorporated CSL recently completed the acquisition of the expanded polystyren...

Zacks · via Yahoo Finance 19 Dec 2024

Carlisle Companies Incorporated (NYSE:CSL) saw a double-digit share price rise of over 10% in the...

Simply Wall St. · via Yahoo Finance 8 Dec 2024

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixi...

Zacks · via Yahoo Finance 21 Nov 2024

Robust Revenue Growth: CSL reports a significant increase in revenues, marking a strong financial...

GuruFocus.com · via Yahoo Finance 26 Oct 2024

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via AOL 16 Oct 2024

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via Yahoo Finance 5 Oct 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At L...

Benzinga · via Yahoo Finance 30 Sep 2024

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase ...

Benzinga · via AOL 30 Sep 2024